Literature DB >> 20615299

Audit of safety, efficacy, and cost-effectiveness of local anaesthetic cystodiathermy.

Kim Davenport1, Francis X Keeley, Anthony G Timoney.   

Abstract

INTRODUCTION: The aim of this study was to audit our experience of cystodiathermy under local anaesthetic (LA) at the time of flexible cystoscopy for recurrent superficial bladder transitional cell carcinoma (TCC). PATIENTS AND METHODS: A total of 264 flexible cystoscopies were performed on patients with a past history of TCC. The number and site of recurrences were recorded and selected patients were offered cystodiathermy. Patient tolerability was noted. At follow-up, any recurrence was recorded.
RESULTS: Eighty patients (30%) had 91 procedures showing one or more recurrences. Fifty-one of the 80 patients (64%) were treated with cystodiathermy under LA. All completed treatment. Forty-five (88%) tolerated the procedure well. Forty-seven (92%) treatments were completed within 5 min. At a median follow-up of 15 weeks, 30 (59%) treated patients had no recurrence and three (6%) had recurrence at the site of treatment.
CONCLUSIONS: LA cystodiathermy is an effective and well-tolerated alternative to general anaesthetic cystodiathermy that enables treatment at the time of detection and may, thereby, reduce patient anxiety.

Entities:  

Mesh:

Year:  2010        PMID: 20615299      PMCID: PMC3229385          DOI: 10.1308/003588410X12699663904835

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  13 in total

1.  Cystodiathermy under local anaesthesia using the flexible cystoscope.

Authors:  K German; S T Hasan; C Derry
Journal:  Br J Urol       Date:  1992-05

2.  Recurrence and progression in low grade papillary urothelial tumors.

Authors:  S Holmäng; H Hedelin; C Anderström; E Holmberg; C Busch; S L Johansson
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

3.  Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience.

Authors:  H A Syed; C S Biyani; N Bryan; S J Brough; C S Powell
Journal:  J Endourol       Date:  2001-08       Impact factor: 2.942

4.  Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder.

Authors:  B Leblanc; A J Duclos; F Bénard; J Côté; L Valiquette; J M Paquin; F Mauffette; R Faucher; J P Perreault
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

5.  Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?

Authors:  H W Herr
Journal:  BJU Int       Date:  2001-11       Impact factor: 5.588

6.  The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.

Authors:  S Holmäng; H Hedelin; C Anderström; S L Johansson
Journal:  J Urol       Date:  1995-06       Impact factor: 7.450

7.  Superficial bladder cancer: progression and recurrence.

Authors:  N M Heney; S Ahmed; M J Flanagan; W Frable; M P Corder; M D Hafermann; I R Hawkins
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

8.  Laser treatment in urology: our experience with neodymium:YAG and carbon dioxide lasers.

Authors:  G Sakkas; A Karagiannis; D Karayannis; K Dimopoulos
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

9.  Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.

Authors:  S Machele Donat; Amanda North; Guido Dalbagni; Harry W Herr
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

10.  Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia.

Authors:  Morten Jønler; Lars Lund; Søren Bisballe
Journal:  BJU Int       Date:  2004-08       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.